China

Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment
Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment
Endpoints
Sarepta Therapeutics
Genethon
Duchenne Muscular Dystrophy
gene therapy
China
Pluristem
Flag link:
FDA lifts warning letter on Zimmer Biomet plant in China
FDA lifts warning letter on Zimmer Biomet plant in China
Mass Device
FDA
warnings
Zimmer Biomet
devices
China
Flag link:
New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing
New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing
Endpoints
China
venture capital
Platelet BioGenesis
platelet manufacturing
Flag link:
Boehringer Ingelheim opens large manufacturing facility in China
Boehringer Ingelheim opens large manufacturing facility in China
BioPharma Dive
Boehringer Ingelheim
China
drug manufacturing
Flag link:
Chinese Regulators Set Procedures for Medical Device Expert Panel Meetings
Chinese Regulators Set Procedures for Medical Device Expert Panel Meetings
Emergo
China
devices
Flag link:
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Bristol-Myers wins approval in China for oral treatment for chronic hepatitis C virus
Marketwatch
Bristol-Myers Squibb
China
hepatitis C
Daklinza
Flag link:
China pharma poised for explosive growth, Novartis CEO says
China pharma poised for explosive growth, Novartis CEO says
Fierce Pharma
China
Novartis
Pharma CEOs
Joe Jimenez
Flag link:
How US Drugmakers Profit From China's Biotech Boom
How US Drugmakers Profit From China's Biotech Boom
Investopedia
China
biotech
Merck
Eli Lilly
Tesaro
Flag link:
China FDA getting rid of medical device testing fees
China FDA getting rid of medical device testing fees
Mass Device
China
FDA
devices
Flag link:
New guidelines to make China a more drug-friendly market
New guidelines to make China a more drug-friendly market
BioPharma Dive
China
CFDA
Flag link:
AstraZeneca’s Lung Cancer Drug Secures China Approval
AstraZeneca’s Lung Cancer Drug Secures China Approval
Investopedia
AstraZeneca
China
Tagrisso
non-small cell lung cancer
Flag link:
J&J CEO: US needs to focus on the long-term sustainability of health care
J&J CEO: US needs to focus on the long-term sustainability of health care
CNBC
JNJ
Pharma CEOs
Alex Gorsky
healthcare reform
China
Flag link:
Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis
Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis
Yahoo
Pfizer
China
Xeljanz
rheumatoid arthritis
Flag link:
China Adds A Pharma Billionaire After Stock Soars
China Adds A Pharma Billionaire After Stock Soars
Forbes
China
Shenzhen Kangtai Biological
Flag link:
Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK
Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK
Endpoints
Chi-Med
fruquintinib
oncology
cancer
China
Flag link:
Inovio Inks $35M Chinese Drug License Deal
Inovio Inks $35M Chinese Drug License Deal
Investopedia
Inovio
China
VGX-3100
Apollo Bio
Flag link:
Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round
Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round
Endpoints
Novartis
biosimilars
Zioxtenzo
Europe
Amgen
Neulasta
China
Flag link:
Meet The Chinese Company That Wants To Be The Intel Of Personalized Medicine
Meet The Chinese Company That Wants To Be The Intel Of Personalized Medicine
Forbes
China
personalized medicine
Flag link:
China fines Medtronic $17 million on anti-monopoly charges
China fines Medtronic $17 million on anti-monopoly charges
Yahoo/AP
China
Medtronic
monopoly
fines
devices
Flag link:
Sanofi and JHL Biotech Announce Strategic Biologics Alliance in China
Sanofi and JHL Biotech Announce Strategic Biologics Alliance in China
Yahoo
Sanofi
JHL Biotech
China
biologics
drug development
Flag link: